NO20001934L - 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse - Google Patents

3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse

Info

Publication number
NO20001934L
NO20001934L NO20001934A NO20001934A NO20001934L NO 20001934 L NO20001934 L NO 20001934L NO 20001934 A NO20001934 A NO 20001934A NO 20001934 A NO20001934 A NO 20001934A NO 20001934 L NO20001934 L NO 20001934L
Authority
NO
Norway
Prior art keywords
preparation
derivatives
substituted
substituted tetrahydropyridopyrimidinone
tetrahydropyridopyrimidinone derivatives
Prior art date
Application number
NO20001934A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001934D0 (no
Inventor
Wilfried Lubisch
Uta Dullweber
Dorothea Starck
Gerd Steiner
Alfred Bach
Franz Emling
Xavier Garcia-Ladona
Hans-Juergen Teschendorf
Karsten Wicke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20001934D0 publication Critical patent/NO20001934D0/no
Publication of NO20001934L publication Critical patent/NO20001934L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Structure And Mechanism Of Cameras (AREA)
NO20001934A 1997-10-24 2000-04-13 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse NO20001934L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19747063A DE19747063A1 (de) 1997-10-24 1997-10-24 3-substituierte Tetrahydropyridopyrimidinon-Derivate, ihre Herstellung und Verwendung
PCT/EP1998/006305 WO1999021857A1 (de) 1997-10-24 1998-10-05 3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO20001934D0 NO20001934D0 (no) 2000-04-13
NO20001934L true NO20001934L (no) 2000-04-13

Family

ID=7846539

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001934A NO20001934L (no) 1997-10-24 2000-04-13 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse

Country Status (27)

Country Link
US (1) US6414157B1 (es)
EP (1) EP1025100B1 (es)
JP (1) JP2001521035A (es)
KR (1) KR20010015787A (es)
CN (1) CN1277611A (es)
AR (1) AR015466A1 (es)
AT (1) ATE212346T1 (es)
AU (1) AU748666B2 (es)
BG (1) BG104291A (es)
BR (1) BR9812970A (es)
CA (1) CA2305258A1 (es)
CO (1) CO4980862A1 (es)
DE (2) DE19747063A1 (es)
DK (1) DK1025100T3 (es)
ES (1) ES2172222T3 (es)
HR (1) HRP980554A2 (es)
HU (1) HUP0004648A3 (es)
ID (1) ID24633A (es)
NO (1) NO20001934L (es)
NZ (1) NZ503486A (es)
PL (1) PL340034A1 (es)
PT (1) PT1025100E (es)
SK (1) SK3872000A3 (es)
TR (1) TR200001102T2 (es)
TW (1) TW432063B (es)
WO (1) WO1999021857A1 (es)
ZA (1) ZA989664B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900544A1 (de) * 1999-01-11 2000-07-13 Basf Ag Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie
AU2003253186A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
WO2004041210A2 (en) 2002-11-05 2004-05-21 Smithkline Beecham Corporation Antibacterial agents
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US7160888B2 (en) * 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
DE102004020908A1 (de) * 2004-04-28 2005-11-17 Grünenthal GmbH Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen
EA200701856A1 (ru) * 2005-04-01 2008-02-28 Уорнер-Ламберт Компани Ллс Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении
CA2621164A1 (en) * 2005-08-26 2007-03-01 Shionogi & Co., Ltd. Derivative having ppar agonistic activity
CN102952129B (zh) * 2011-08-16 2015-09-23 上海师范大学 四氢吡啶并二氢嘧啶酮衍生物及其制备方法和应用
AU2021365812A1 (en) 2020-10-21 2023-05-11 Aligos Therapeutics, Inc. Bicyclic compounds
US11957683B2 (en) 2021-06-18 2024-04-16 Aligos Therapeutics, Inc. Bicyclic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0827149A (ja) * 1994-07-08 1996-01-30 Meiji Seika Kaisha Ltd ピリミジノン誘導体およびその塩

Also Published As

Publication number Publication date
AU748666B2 (en) 2002-06-06
ES2172222T3 (es) 2002-09-16
ZA989664B (en) 2000-04-25
DE59802922D1 (de) 2002-03-14
HUP0004648A3 (en) 2001-11-28
PL340034A1 (en) 2001-01-15
BG104291A (en) 2001-05-31
EP1025100A1 (de) 2000-08-09
DK1025100T3 (da) 2002-05-06
CA2305258A1 (en) 1999-05-06
NZ503486A (en) 2001-04-27
CN1277611A (zh) 2000-12-20
EP1025100B1 (de) 2002-01-23
AU9748498A (en) 1999-05-17
WO1999021857A1 (de) 1999-05-06
KR20010015787A (ko) 2001-02-26
TR200001102T2 (tr) 2000-08-21
HUP0004648A2 (hu) 2001-05-28
NO20001934D0 (no) 2000-04-13
SK3872000A3 (en) 2000-09-12
PT1025100E (pt) 2002-07-31
US6414157B1 (en) 2002-07-02
ID24633A (id) 2000-07-27
BR9812970A (pt) 2000-08-08
CO4980862A1 (es) 2000-11-27
JP2001521035A (ja) 2001-11-06
DE19747063A1 (de) 1999-04-29
ATE212346T1 (de) 2002-02-15
TW432063B (en) 2001-05-01
HRP980554A2 (en) 1999-08-31
AR015466A1 (es) 2001-05-02

Similar Documents

Publication Publication Date Title
NO20075066L (no) Farmasoytisk sammensetning som inneholder isoflavoner
NO991761L (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
DK0624595T3 (da) Nor-galdesyrederivater, fremgangsmåde til deres fremstilling og anvendelse af disse forbindelser som lægemidler
NO20020684L (no) 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
NO993003D0 (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
NO20021689L (no) 5-leddede heterocykliske derivater, fremstilling derav og anvendelse som medikamenter
DK0871606T3 (da) Nye forbindelser og deres præparat med anti-inflammatorisk og anti-thrombotisk aktivitet
NO20006029L (no) Pyrazolinderivater, deres fremstilling og anvendelse som legemidler
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
NO305657B1 (no) 4-substituerte piperidinderivater og farmas°ytisk preparat derav
NO20001934L (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
WO2002070469A3 (en) Selective pde3b inhibitors and use of the same in therapy
NO971625L (no) Nye peptider med immunomodulatoriske effekter
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
NO20002124L (no) Nye karboksylsyrederivater med amid-sidekjeder, deres fremstilling og anvendelse som endothelin-reseptorantagonister
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
DK1015437T3 (da) Benzoxazin- og benzothiazin-derivater og deres anvendelse i lægemidler
NO20006547L (no) Salter av paroxetine
MY127675A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
NO20042846L (no) Derivater av 5-(pyridin-3-yl)-1-azabicyklo[3.2.1]oktan, fremstilling derav og anvendelse av de samme som terapeutiske midler
NO975130L (no) <alfa>-(substituerte alkylfenyl)-4-(hydroxydifenylmethyl)-1-piperidinbutanolderivater, deres fremstilling og deres anvendelse som antihistaminer, anti-allergimidler og bronchodilatorer
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
DK1104419T3 (da) N-substituerede azabicyloheptan-derivater, deres fremstilling og anvendelse
NO20055142L (no) Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application